class i histone deacetylase inhibitor entinostat suppresses regulatory t cells and enhances immunotherapies in renal and prostate cancer models类我组蛋白脱乙酰酶抑制剂entinostat抑制调节性t细胞,增强免疫疗法在肾和前列腺癌模型.pdfVIP

下载本文档

2
0
约7.95万字
约 14页
2017-08-31 发布于上海
举报

class i histone deacetylase inhibitor entinostat suppresses regulatory t cells and enhances immunotherapies in renal and prostate cancer models类我组蛋白脱乙酰酶抑制剂entinostat抑制调节性t细胞,增强免疫疗法在肾和前列腺癌模型.pdf

class i histone deacetylase inhibitor entinostat suppresses regulatory t cells and enhances immunotherapies in renal and prostate cancer models类我组蛋白脱乙酰酶抑制剂entinostat抑制调节性t细胞,增强免疫疗法在肾和前列腺癌模型

Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models 1 2 1 1 1 1 Li Shen , Michael Ciesielski , Swathi Ramakrishnan , Kiersten M. Miles , Leigh Ellis , Paula Sotomayor , 3 2 1 Protul Shrikant , Robert Fenstermaker , Roberto Pili * 1 Department of Medicine, Roswell Par

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

class i histone deacetylase inhibitor entinostat suppresses regulatory t cells and enhances immunotherapies in renal and prostate cancer models类我组蛋白脱乙酰酶抑制剂entinostat抑制调节性t细胞,增强免疫疗法在肾和前列腺癌模型.pdfVIP